Venkat Krishnan

Related News »
Absorica will be the flagship brand for Ranbaxy's specialised dermatology sales force, Venkat Krishnan, senior vice president, Ranbaxy for America region said. Valued $4 billion, Ranbaxy Laboratories shares ended down 0.9 percent at 525.20 rupees.
May 28, 2012 at 11:06 | Source: Reuters India
Absorica will be the flagship brand for Ranbaxy's specialised dermatology sales force, Venkat Krishnan, senior vice president, Ranbaxy for America region said. Valued USD 4 billion, Ranbaxy Laboratories shares ended down 0.9% at Rs 525.20.
May 28, 2012 at 14:27 | Source: MoneyControl.com
Ranbaxy America's Senior Vice-President and Regional Director Venkat Krishnan said Absorica was a critical milestone in the commitment to serve the dermatology community and would be the flagship brand for Ranbaxy's specialised dermatology sales force.
May 28, 2012 at 19:20 | Source: The Hindu
Commenting on the development, Ranbaxy Americas senior vice-president and regional director Venkat Krishnan said: “Absorica is a critical milestone in our commitment to serve the dermatology community and will be the flagship brand for Ranbaxy’s ...
May 28, 2012 at 10:52 | Source: Livemint.com
Absorica is a critical milestone in our commitment to serve the dermatology community and will be the flagship brand for Ranbaxy's specialized dermatology sales force," said Venkat Krishnan, Senior Vice President and Regional Director, Americas.
May 28, 2012 at 11:28 | Source: Stockhouse